<!DOCTYPE html>
<html>
<head>
	<!-- ========================================
	     WEBSITE TITLE (appears in browser tab)
	     ======================================== -->
	<title>observer effect</title>
	
	<!-- DON'T DELETE: Links to your CSS file -->
	<link href="amoeba.css" rel="stylesheet" type="text/css" media="all">
	<meta name="viewport" content="width=device-width, initial-scale=1">
	<meta charset="utf-8">
</head>

<body>

<!-- ========================================
     HEADER (Top of page)
     ======================================== -->
<header id="top">

	<!-- CHANGE THIS: Your website name -->
	<div>synthesis</div>

	<!-- NAVIGATION MENU
	     To add more links: copy a line and paste
	     To remove links: delete a line
	     Put your page URL inside href="" -->
	<nav>
		<a href="template.html">home</a>
		<a href="synthesis.html">synthesis</a>
		<a href="page4.html">dissection [wip]</a>
		<!-- ADD MORE LINKS BY COPYING THE LINE ABOVE -->
	</nav>

</header>


<!-- ========================================
     MAIN CONTENT AREA
     ======================================== -->
<main>

	<!-- BIG HEADING (shows at top of page) -->
	<h1></h1>

	<!-- ========================================
	     CONTENT SECTION
	     Each <section> creates a box with border
	     ======================================== -->
	<section> 

		<!-- DIFFERENT HEADING SIZES (biggest to smallest) -->
		<h2>role of the gut-brain axis in mental health</h2>
		<h3>background</h3>
		<h4></h4>
		<h5></h5>
		<h6></h6>
		
		<!-- PARAGRAPH TEXT -->
		<p>
            Our understanding of major depressive disorder (MDD) has undergone influential changes over the past decade.
            Transitioning from localized neurochemical imbalances, the model now encompasses a systemic, multi-organ pathology
            which, interestingly, includes the gut microbiota. The microbiota-gut-brain-axis (MGBA) has come to 
            embody a "bidrectional communication network" that connects the central nervous system (CNS) with the enteric nervous system (ENS).
            <br><br>
            As an independent highschool student, I aim to synthesize some of the latest research in this field in the form of a literature 
            review.
            <hr>
            <h5><strong>Disclaimer:</strong></h5> <strong>This project is an independent literature review and exploratory analysis
                 conducted for educational purposes, stemming from personal interest.
                 <br> It is not intended for clinical or diagnostic use.</strong>
                 
            
        </p>
    
        <section>
        <h3>research question</h3>
		<blockquote>
			<p>"How have recent studies conceptualized the relationship between the microbiota-gut-brain-axis (MGBA) and Major Depressive Disorder (MDD)?"</p>
			<cite></cite>
		</blockquote> 
	</section>

	</section>

	<!-- ========================================
	     TABLES SECTION
	     ======================================== -->
	<section>
		<h3> selected literature</h3>
		<!-- TABLE 1: Simple 3x3 table with numbers -->
		<table>
			<!-- HEADER ROW (top row, bold text) -->
			<thead>
				<tr> 
					<th>Paper Title</th> 
					<th>Primary Author, Year</th> 
					<th>Journal</th> 
                    <th>Reason for Selection</th>
					<!-- TO ADD MORE COLUMNS: copy <th>Column X</th> -->
				</tr>
			</thead>
			
			<!-- TABLE BODY (your data goes here) -->
			<tbody>
				<tr> 
					<td>Gut Microbiome-Wide Association Study of Depressive Symptoms</td> 
					<td>Radjabzadeh, D. (2022)</td> 
					<td>Nature Communications</td> 
                    <td>Identified 13 specific taxa associated with symptoms in the largest population-based study to date (N=2,539).
                        <a href="https://www.nature.com/articles/s41467-022-34502-3">(1)</a></td>
					<!-- TO ADD MORE COLUMNS: copy <td>Number</td> -->
				</tr>
				<tr> 
					<td>Perturbations in Gut Microbiota Composition in Psychiatric Disorders</td> 
					<td>Nikolova, V.L. (2021)</td> 
					<td>JAMA Psychiatry</td> 
                    <td>Established shared "anti-inflammatory" microbial depletion across MDD, bipolar disorder, and schizophrenia.
                        <a href="https://jamanetwork.com/journals/jamapsychiatry/fullarticle/2784328">(2)</td>
				</tr>
				<tr> 
					<td>Acceptability, Tolerability, and Estimates of
                        Putative Treatment Effects of Probiotics as Adjunctive Treatment in Patients With Depression</td> 
					<td>Nikolova, V. L. (2023)</td> 
					<td>JAMA Psychiatry</td> 
                    <td>Provided definitive RCT evidence for multi-strain 
                        probiotics as an adjunct to standard antidepressant therapy.
                        <a href="https://jamanetwork.com/journals/jamapsychiatry/fullarticle/2806011">(3)</td>
				</tr>
				
                <tr> 
					<td>Bifidobacterium breve CCFM1025 attenuates major depression disorder 
                    via regulating gut microbiome and tryptophan metabolism</td> 
					<td>Tian, P. (2022)</td> 
					<td>Brain, Behavior, and Immunity</td> 
                    <td>Demonstrated a clear causal link between a specific probiotic strain, tryptophan levels, and clinical symptom relief.
                        <a href="https://www.sciencedirect.com/science/article/abs/pii/S0889159121006267">(4)</td>
				</tr>
                <tr> 
					<td>Effects of a probiotic add-on treatment on fronto-limbic brain structure, function, and perfusion in depression</td> 
					<td>Schaub, A. C., Yamanbaeva G. (2023)</td> 
					<td>Journal of Affective Disorders</td> 
                    <td>Documented structural neural preservation (uncinate fasciculus) following gut microbiota modulation.
                        <a href="https://www.sciencedirect.com/science/article/pii/S016503272201504X">(5)</td></td>
				</tr>
                <tr> 
					<td>A pilot exploration of multi-omics research of gut microbiome in major depressive disorders</td> 
					<td>Various (2022)</td> 
					<td>Translational Psychiatry</td> 
                    <td>Integrated metagenomics, metabolomics, and MRI to identify systemic "microbiota-immune-brain" biosignatures.
                        <a href="https://www.nature.com/articles/s41398-021-01769-x">(6)</td>
				</tr>
    
			</tbody>
		</table>
     </section>
		
    
        <section>
        <h2>qualitative patterns across studies</h2>
            <p>I noted several consistent patterns that emerged from these studies:</p>
            <p>
                <ul>
            <li><strong>Shared microbial depletion: </strong>A common feature across several psychiatric disorders, including MDD, is 
            the <strong>loss</strong> of beneficial, <strong>anti-inflammatory bacteria</strong>
            (particularly <em>Faecalibacterium</em> and <em>Coprococcus</em>).</li>
            <li><strong>Inflammatory signature: </strong>Depresspion is consistently linked with an <strong>increase in pro-inflammatory bacteria</strong>
            (e.g. <em>Eggerthella</em>) alongside a state of systemic <strong>brain inflammation</strong>.</li>
            <li>
                <strong>Multiple, converging pathways to the brain: </strong> The studies persistently validate the three core communication
                routes of the MGBA:
                <ol>
                    <li>
                        <strong>Neural:</strong> The vagus nerve acts as <strong>direct information superhighway</strong>, conveying information
                            to the brain about gut microbial activity.
                    </li>
                    <li><strong>Endocrine/Stress:</strong> The gut microbiota is essential for calibrating the body's stress response system 
                        <strong>(HPA axis)</strong>; microbial depletion thus leads to <strong>hyperactivity</strong> linked to depression.
                        </li>
                    <li>
                        <strong>Immune: </strong>Dysbiosis causes "leaky gut", which allows inflammatory bacterial fragments (LPS)
                        into circulation. This triggers <strong> systemic and brain inflammation</strong> (neuroinflammation), commonly seen in MDD.
                    </li>
                </ol>
            <li><strong>Gut-targeted intervention: </strong>
                Perhaps the most consistent observation in these clinical trials is the efficacy of <strong>multi-strain probiotics</strong>
                that act as legitimate psychobiotic interventions, improving symptoms, regulating the underlying biology (e.g. metabolism, inflammation),
                and protecting brain structure.
            </li>
            </li>
            </ul>
            </p>
            <hr>
    
        <h2>descriptive statistical synthesis</h2>
        <ul>
            <li><h5>Clinical efficacy of Probiotics: </h5>
                <ul>
                    <li>
                        In the 2023 Niklova et al. RCT, the probiotic group showed a <strong>Standardized Effect Size (SES)</strong>
                        of <strong>0.70</strong> at 4 weeks and <strong>0.64</strong> at 8 weeks.
                        <br>
                        In psychiatric research, based on guidelines, an SES > 0.5 is considered a <strong>moderate to large effect</strong>,
                        indicating a meaningful correlation beyond pure chance.
                    </li>
                    </ul>
                </ul>
                    <ul>
                    <li>
                        <h5>Microbial changes in specific populations:</h5>
                        <ul>
                            <li>
                                In adolescents with depression, the decrease in diversity of the gut microbiota was <strong>severe</strong>.
                                The <strong>Standardized Mean Difference (SMD)</strong> was recorded to be a whopping <strong>-0.92</strong>. 
                                <br>
                                This large negative SMD indicates a substantial and significant loss of diversity.
                            </li>
                            <li>
                                Upon treatment with <em> Lactobacillus plantarum</em> PS128, adolescents yielded a <strong>mean score reduction</strong>
                                0f <strong>-4.2</strong> on the <strong>Hamilton Depression Scale</strong>, showcasing a significant
                                clinical improvement.
                            </li>
                        </ul>
                    </li>
                </ul>
                <hr>
                <h2>limitations</h2>
                <p>
                    There are some limitations reported by the papers which are essential to acknowledge:
                    <ol>
                        <li>
                            <strong>Heterogenity in individual response: </strong> A current major concern is why some patients benefit dramatically
                            from gut-specific treatment whereas others show no response.
                        </li>
                        <li>
                            <strong>Short trial durations: </strong> Many of the trials run for 4-8 weeks, which limits conclusions about long-term effects.
                        </li>
                        <li><strong>Underexploration: </strong> The mycobiome and its connection to psychiatry is an emerging field; the research is promising
                            but remains in its early stages.
                        </li>
                    </ol>
                </p>
                <hr>
        <h2>conclusions</h2>
                <p>
                   This literary synthesis firmly establishes the MGBA axis as a <strong>central focal point</strong>
                   in understanding the biology behind MDD. MDD is best understood as a <strong>systemic condition</strong>,
                   involving coordinated dysregulation of the gut microbiome, immune system, endocrine stress response,
                   and brain circuitry, thereby replacing the outdated "serotonin-deficiency" model.
                   <br>
                   Across the studies reviewed, there emerges a cohesive biosignature:
                   <ul>
                    <li>Microbial dysregulation leading to inflammation</li>
                    <li>Structural and functional alterations in the emotion-regulating circuitry of the brain</li>
                   </ul>
                   Furthermore, the literature supports using <strong>probiotics</strong> as a biologically safe and 
                   reasonable addition to standard antidepressant therapy, demonstrating clear, measurable effects at clinical,
                   molecular and neural levels.
                </p>
        
        </section>


	</section>

    <section>
        <h2>my experience</h2>
        The first time I heard about this strange neurochemical interaction was in 2022, from a Youtube video featuring
        the neuroscientist and professor Andrew Huberman. At first, I refused to believe it and dismissed it as 
        just another minor fringe correlational relationship, observed purely by chance. Biology is, after all, unfortunately rich in them.
        <br><br>
        However, as time went on and research progressed, my subsequent analyses proved otherwise. I don't think I have ever been this glad to be proven wrong.
        <br><br>
        This excitingly promising link between seemingly unrelated phenomena has fascinated me incredibly. I find myself curious
     to explore similar pathways, approaching the human body as a multifaceted and interactive system, specific
        to each individual's biology.
        <br><br>
        Overall, I found this project to be highly engaging and intellectually stimulating, while also being disarming. While conducting this review
        I realized that scientific understanding often happens through overlapping and sometimes <strong>incomplete</strong>
        evidence rather than cold, definitive answers. Practically, this has changed how I process and approach scientific literature, becoming more
        comfortable balancing skepticism with interest. I look forward to continuing several more projects along this line.
        
    </section>


<!-- "BACK TO TOP" BUTTON (fixed in corner) -->
<div class="up"><a href="#top">â†‘ Back to Top</a></div>


<!-- ========================================
     FOOTER (bottom of page)
     ======================================== -->
<footer>
	Website by Nuha Nazia
</footer> 

<!-- ========================================
     CLICKING SOUND EFFECT
     To add click sounds to links:
     1. Find a short sound file (like "click.mp3")
     2. Put it in your website folder
     3. Remove the around this code -->
<!--
<audio id="clickSound" src="click.mp3" preload="auto"></audio>
<script>
	// This makes sound play when you click any link
	document.querySelectorAll('a').forEach(link => {
		link.addEventListener('click', function() {
			document.getElementById('clickSound').play();
		});
	});
</script>
-->

</body>
</html>